Resources
Texas PCSK9 Report Card – August 2022
Texas’ rate of heart disease is higher than the national average. Yet insurers are more likely to reject Texans’ prescriptions for cholesterol-lowering medication.
Mississippi PCSK9 Report Card – August 2022
Mississippi’s rate of heart disease is higher than the national average. Yet insurers are more likely to reject Mississippians’ prescriptions for cholesterol-lowering medication.
Arkansas PCSK9 Report Card – August 2022
Arkansas’ rate of heart disease is higher than the national average. Yet insurers are more likely to reject Arkansans’ prescriptions for cholesterol-lowering medication.
Rejected: How Life-Saving Heart Medication Eludes Women, Southerners and People of Color
Infographic
2022 Cardiovascular Health Policy Summit Report
The fifth annual Cardiovascular Health Policy Summit welcomed policy experts, patient advocates and health care providers to address patients’ pressing needs and explore policy solutions that will improve the lives of Americans with cardiovascular disease.
New Data Show Certain Demographics are Denied Cholesterol-Lowering Medication More Often
Medication access remains a hurdle for many patients, especially those prescribed cholesterol-lowering PCSK9 inhibitors.
Rejected: How Life-Saving Heart Medication Eludes Women, Southerners & People of Color
Every 36 seconds, someone in the United States dies from cardiovascular disease. In fact, heart disease is the leading cause of death in America, responsible for one in every four adult fatalities. Making sure patients can access medication that protects their hearts should be a top national health care priority. But recent insurance claims data […]
Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers
Letter to FTC requesting public comments on the business practices of PBMs.
New Medication Offers New Hope for Heart Patients
Things are looking up for patients who have an uncommon heart condition. The Food and Drug Administration last month approved a novel medication to treat obstructive hypertrophic cardiomyopathy.
Landmark Discovery Could Help Patients Cut Excess Weight
“A few of my patients are kids. Others are over age 90. But nearly all are overweight or obese.”
Addressing Unmet Needs in Peripheral Artery Disease
Infographic
Addressing Unmet Needs in Peripheral Artery Disease
As an aging America faces rising rates of obesity and diabetes, people may also find themselves facing a dangerous cardiovascular disease.